R
RAPT Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
Get all premium features to the best stock analysis tool
58.02
0.00 (0.00%)
This stock has a consensus price target of $40.57 based on the ratings of 19 analysts. The high is $70.00 and the low is $4.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 4 | $ 40.57 | $ 70 |
| Change | -93.10% | -30.06% | 20.68% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-01-21 | -0.03% | Barclays | $58 | Downgrades | Overweight → Equal-Weight |
| 2026-01-21 | -0.03% | Leerink Partners | $58 | Downgrades | Outperform → Market Perform |
| 2026-01-20 | -0.03% | Wells Fargo | $58 | Downgrades | Overweight → Equal-Weight |
| 2026-01-20 | — | LifeSci Capital | — | Downgrades | Outperform → Market Perform |
| 2026-01-20 | — | TD Cowen | — | Downgrades | Buy → Hold |